MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517047320 A) filed by Merck Sharp & Dohme Llc, Rahway, U.S.A., on May 16, for 'pnu anthracycline derivatives and methods of use thereof.'
Inventor(s) include Chen, Sijie; Flygare, John A.; Johnson, Rebecca Elizabeth; Lang, Simon B; Morales, Christian L.; Quiroz, Ryan; Seganish, W. Michael; Tong, Ling; and Wen, Xin.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure is directed to novel PNU Anthracycline Derivatives of formula (I): and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the above disclosure. The disclosure is also directed to pharmaceutical compositions comprising the PNU Anthracycline Derivatives, and the use of these compounds and compositions in the prevention or treatment of cellular proliferative disorders."
The patent application was internationally filed on Oct. 24, 2023, under International application No.PCT/US2023/077570.
Disclaimer: Curated by HT Syndication.
